Two groups of researchers say that experimental CAR-T cell therapies have shrunk tumors in a matter of days in patients with recurrent glioblastoma, a deadly brain cancer, who got a single infusion of the engineered cells directly into their heads earlier this year.
Both teams treated patients whose…
Click here to view original post
